iShares Core MSCI EAFE ETF vs JBS N.V. Class A Common Shares — how do they compare? iShares Core MSCI EAFE ETF trades at $95.79 (market cap $188.50B), while JBS N.V. Class A Common Shares trades at $13.13 (market cap $13.96B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 13.5× JBS N.V. Class A Common Shares's market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 41 Days and JBS N.V. Class A Common Shares for 0 Days on average.
| IEFA | JBS | |
|---|---|---|
Market Cap | $188.50B | $13.96B |
Volume | 5,885,862 | 5,326,589 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $101.41 | $18.42 |
52-Week Low | $85.06 | $10.86 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $34.93B |
Dividend Yield | — | 10.31% |
Signals from Pluang's Aura AI — not financial advice
IEFA (iShares Core MSCI EAFE ETF) trades at $96.64 with a slight 0.48% daily gain, though technical indicators show a bearish bias with moving averages signaling caution. The ETF provides exposure to developed international markets outside North America, managing $196 billion in assets with competitive expense ratios. Recent comparisons highlight its size advantage over competitors like Schwab's SCHF and State Street's SPDW, though some alternatives have shown stronger recent performance.
The outlook remains mixed with defensive capital flows supporting international diversification benefits, but technical weakness and competitive pressure from lower-cost alternatives present headwinds. Key opportunities include reduced S&P 500 concentration risk and higher dividend yields, while risks involve underperformance versus global peers and limited emerging market exposure.
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →